Kirobo Robot Astronaut to Return to Earth from the International Space Station

Dentsu Inc. (TOKYO: 4324) (ISIN: JP3551520004) (President & CEO: Tadashi Ishii; Head Office: Tokyo; Capital: 74,609.81 million yen) announced today that Kirobo, the robot astronaut that spent eighteen months aboard the International Space Station (ISS), is scheduled to return to Earth tomorrow.

According to the National Aeronautics and Space Administration (NASA) in the USA, Kirobo will board SpaceX’s CRS-5 Dragon cargo supply spacecraft at 7:09 p.m. on Tuesday, February 10 (Greenwich Mean Time) and leave the ISS. The spacecraft is expected to splash down in the Pacific Ocean at 0:44 a.m. on Wednesday, February 11 (Greenwich Mean Time). A debriefing session on Kirobo’s return to Japan is scheduled to be held in Japan in late March.

Kirobo and Japan Aerospace Exploration Agency (JAXA) astronaut Koichi Wakata held the world’s first conversation experiment between a robot and a human in outer space, and conducted research for a future in which humans and robots coexist.

Robot astronaut Kirobo was developed under the KIBO ROBOT PROJECT, a joint research project carried out in collaboration with the University of Tokyo’s Research Center for Advanced Science and Technology, ROBO GARAGE Co., Ltd., Toyota Motor Corporation, and the Japan Aerospace Exploration Agency (JAXA).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.